06 maggio 2021 12:51
Fonte: Adnkronos
#salute-e-benessere
- Roche and Lilly will integrate data from Lilly s connected insulin pen solution into the mySugr app in several countries.
- Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.
- By collaborating with Lilly, Roche accelerates growth of its open ecosystem enabling its strategy of integrated Personalised Diabetes Management (iPDM).
BASEL, Switzerland, May 6, 2021 /PRNewswire/ Roche today announced that it has signed a collaboration agreement with Eli Lilly and Company, a global leader in diabetes care delivering innovative solutions including medicines and technologies, to work towards optimising the management of insulin pen therapy. By collaborating with Lilly, Roche follows its ambition to create an open ecosystem including its own and partner devices, solutions and services, a
Eli Lilly: accords avec quatre entreprises autour du diabèt abcbourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abcbourse.com Daily Mail and Mail on Sunday newspapers.